Phase 1 HR+/HER2- Ductal and Lobular Breast Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Triple-Negative Breast CancerColorectal, CancerSoft Tissue Sarcoma+3 more

Novartis Pharmaceuticals180 enrolled8 locationsNCT07261631

Recruiting

Phase 1

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Triple-Negative Breast CancerColorectal, CancerNon-small Cell Lung Cancer+2 more

Novartis Pharmaceuticals162 enrolled31 locationsNCT06562192